Biolog to Expand Bacterial, Fungal Phenotyping Platform to Human and Other Mammalian Cells | GenomeWeb

Having carved out a truly unique niche in “high-throughput” microbiology, Biolog, of Hayward, Calif., is now seeking to broaden its flagship technology — the Phenotype MicroArray — to encompass mouse, human, and other mammalian cell lines.

The Phenotype MicroArray (PM) technology allows researchers to simultaneously assess as many as 2,000 individual phenotypes in bacterial or fungal cells of interest using a standard 96-well assay plate in combination with the OmniLog, the company’s cell incubator-cum fluorescence plate reader.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.